The interim access policy went to OMB review, and Hims & Hers shares rose nearly 6%. Leerink sizes the possible market at $2.2B a year.
Recap by typeshit. Full story at Stocktwits.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
The Telangana Drugs Control Administration issued a strict warning over unapproved weight-loss drugs and peptides being sold online in the Indian state.
Sources tell CNBC the plan would let pharmacies temporarily compound popular peptides like BPC-157, despite FDA staff safety concerns.
The plan would let compounding pharmacies temporarily make popular peptides like BPC-157, per two people familiar with it, even though FDA staff scientists flagged safety gaps.
Loading…